140 related articles for article (PubMed ID: 24406780)
1. Angiotension receptor blockers reduce the risk of dementia.
Chiu WC; Ho WC; Lin MH; Lee HH; Yeh YC; Wang JD; Chen PC;
J Hypertens; 2014 Apr; 32(4):938-47. PubMed ID: 24406780
[TBL] [Abstract][Full Text] [Related]
2. Angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers reduced dementia risk in patients with diabetes mellitus and hypertension.
Kuan YC; Huang KW; Yen DJ; Hu CJ; Lin CL; Kao CH
Int J Cardiol; 2016 Oct; 220():462-6. PubMed ID: 27390970
[TBL] [Abstract][Full Text] [Related]
3. Long-term use of angiotensin II receptor blockers and risk of cancer: a population-based cohort analysis.
Wang KL; Liu CJ; Chao TF; Huang CM; Wu CH; Chen TJ; Chiang CE
Int J Cardiol; 2013 Sep; 167(5):2162-6. PubMed ID: 22709730
[TBL] [Abstract][Full Text] [Related]
4. Retrospective analysis of real-world efficacy of angiotensin receptor blockers versus other classes of antihypertensive agents in blood pressure management.
Petrella R; Michailidis P
Clin Ther; 2011 Sep; 33(9):1190-203. PubMed ID: 21885126
[TBL] [Abstract][Full Text] [Related]
5. Risk of acute myocardial infarction, stroke, or death in patients initiating olmesartan or other angiotensin receptor blockers - a cohort study using the Clinical Practice Research Datalink.
Zhou EH; Gelperin K; Levenson MS; Rose M; Hsueh YH; Graham DJ
Pharmacoepidemiol Drug Saf; 2014 Apr; 23(4):340-7. PubMed ID: 24285502
[TBL] [Abstract][Full Text] [Related]
6. Associations of anti-hypertensive treatments with Alzheimer's disease, vascular dementia, and other dementias.
Davies NM; Kehoe PG; Ben-Shlomo Y; Martin RM
J Alzheimers Dis; 2011; 26(4):699-708. PubMed ID: 21709373
[TBL] [Abstract][Full Text] [Related]
7. Angiotensin-receptor blockers and risk of Alzheimer's disease in hypertension population--a nationwide cohort study.
Hsu CY; Huang CC; Chan WL; Huang PH; Chiang CH; Chen TJ; Chung CM; Lin SJ; Chen JW; Leu HB
Circ J; 2013; 77(2):405-10. PubMed ID: 23149416
[TBL] [Abstract][Full Text] [Related]
8. Comparative risk for angioedema associated with the use of drugs that target the renin-angiotensin-aldosterone system.
Toh S; Reichman ME; Houstoun M; Ross Southworth M; Ding X; Hernandez AF; Levenson M; Li L; McCloskey C; Shoaibi A; Wu E; Zornberg G; Hennessy S
Arch Intern Med; 2012 Nov; 172(20):1582-9. PubMed ID: 23147456
[TBL] [Abstract][Full Text] [Related]
9. Antihypertensive drug use and the risk of dementia in patients with diabetes mellitus.
Johnson ML; Parikh N; Kunik ME; Schulz PE; Patel JG; Chen H; Aparasu RR; Morgan RO
Alzheimers Dement; 2012 Sep; 8(5):437-44. PubMed ID: 22521970
[TBL] [Abstract][Full Text] [Related]
10. Protective Effects of Angiotensin Receptor Blockers on the Incidence of Dementia in Patients with Chronic Kidney Disease: A Population-Based Nationwide Study.
Chen YH; Chen YY; Fang YW; Tsai MH
J Clin Med; 2021 Nov; 10(21):. PubMed ID: 34768695
[TBL] [Abstract][Full Text] [Related]
11. Renoprotective effect of renin-angiotensin-aldosterone system blockade in patients with predialysis advanced chronic kidney disease, hypertension, and anemia.
Hsu TW; Liu JS; Hung SC; Kuo KL; Chang YK; Chen YC; Hsu CC; Tarng DC
JAMA Intern Med; 2014 Mar; 174(3):347-54. PubMed ID: 24343093
[TBL] [Abstract][Full Text] [Related]
12. Cardiovascular death in kidney recipients treated with renin-angiotensin system blockers.
Opelz G; Döhler B
Transplantation; 2014 Feb; 97(3):310-5. PubMed ID: 24492421
[TBL] [Abstract][Full Text] [Related]
13. Diverticular disease and additional comorbidities associated with increased risk of dementia.
Peng YC; Lin CL; Yeh HZ; Tung CF; Chang CS; Kao CH
J Gastroenterol Hepatol; 2016 Nov; 31(11):1816-1822. PubMed ID: 27029523
[TBL] [Abstract][Full Text] [Related]
14. Association Between Angiotensin II Receptor Blockers and the Risk of Lung Cancer Among Patients With Hypertension From the Korean National Health Insurance Service-National Health Screening Cohort.
Moon S; Lee HY; Jang J; Park SK
J Prev Med Public Health; 2020 Dec; 53(6):476-486. PubMed ID: 33296588
[TBL] [Abstract][Full Text] [Related]
15. Cardiovascular and mortality risk in elderly Medicare beneficiaries treated with olmesartan versus other angiotensin receptor blockers.
Graham DJ; Zhou EH; McKean S; Levenson M; Calia K; Gelperin K; Ding X; MaCurdy TE; Worrall C; Kelman JA
Pharmacoepidemiol Drug Saf; 2014 Apr; 23(4):331-9. PubMed ID: 24277678
[TBL] [Abstract][Full Text] [Related]
16. Uptake of angiotensin II receptor blockers in the treatment of hypertension.
Greving JP; Denig P; van der Veen WJ; Beltman FW; Sturkenboom MC; de Zeeuw D; Haaijer-Ruskamp FM
Eur J Clin Pharmacol; 2005 Jul; 61(5-6):461-6. PubMed ID: 15912393
[TBL] [Abstract][Full Text] [Related]
17. Long-term clinical and economic outcomes associated with angiotensin II receptor blocker use in hypertensive patients.
Swindle JP; Buzinec P; Iorga SR; Ramaswamy K; Panjabi S
Curr Med Res Opin; 2011 Sep; 27(9):1719-31. PubMed ID: 21767101
[TBL] [Abstract][Full Text] [Related]
18. Angiotensin-converting enzyme inhibitors, angiotensin-receptor blockers, and risk of appendicitis.
Mukamal KJ; Ghimire S; Pandey R; Fiarman GS; Gautam S
Ann Epidemiol; 2012 Oct; 22(10):747-50. PubMed ID: 22867943
[TBL] [Abstract][Full Text] [Related]
19. Statin use and incident dementia: a nationwide cohort study of Taiwan.
Chou CY; Chou YC; Chou YJ; Yang YF; Huang N
Int J Cardiol; 2014 May; 173(2):305-10. PubMed ID: 24681022
[TBL] [Abstract][Full Text] [Related]
20. Angiotensin Receptor Blockers Decrease the Risk of Major Adverse Cardiovascular Events in Patients with End-Stage Renal Disease on Maintenance Dialysis: A Nationwide Matched-Cohort Study.
Yang CW; Tzeng NS; Yin YJ; Li CH; Chen HA; Chiu SH; Ho SY; Huang HL
PLoS One; 2015; 10(10):e0140633. PubMed ID: 26488749
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
